Analyses of coronary graft patency after aprotinin use: Results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial

Journal of Thoracic and Cardiovascular Surgery

Volumn 116, Issue 5, 1998, Pages 716-730

  Alderman, E L ^a   Levy, J H ^a   Rich, J B ^a   Nili, M ^a   Vidne, B ^a   Schaff, H ^a   Uretzky, G ^a   Pettersson, G ^a   Thiis, J J ^a   Hantler, C B ^a   Chaitman, B ^a   Nadel, A ^a   Westaby, S ^a   Bidstrup, B ^a   Griepp, R B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; HEMOSTATIC AGENT; HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANGIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; GRAFT OCCLUSION; GRAFT PATENCY; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SAPHENOUS VEIN GRAFT;

EID: 0031793958     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(98)00431-0     Document Type: Article

References (30)

1. M Laskowski Jr I Kato Protein inhibitors of proteinases Annu Rev Biochem 49 1980 593 626
2. M Verstraete Clinical applications of inhibitors of fibrinolysis Drugs 29 1985 236 242
3. M Havel F Grabenwoger J Schneider G Laufer G Wollenek A Owen Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood J Thorac Cardiovasc Surg 107 1994 807 810
4. D Royston BP Bidstrup KM Taylor RN Sapsford Effect of aprotinin on need for blood transfusion after repeat open-heart surgery Lancet 2 1987 1289 1291
5. W Van Oeveren NJ Jansen BP Bidstrup Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass Ann Thorac Surg 44 1987 640 645
6. BP Bidstrup D Royston KM Taylor RN Sapsford Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol) J Thorac Cardiovasc Surg 97 1989 364 372
7. DM Cosgrove B Heric BW Lytle PC Taylor R Novoa LA Golding Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study Ann Thorac Surg 6 1992 1031 1036
8. J Lemmer W Stanford S Bonney J Breen E Chomka WJ Eldredge Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency J Thorac Cardiovasc Surg 107 1994 543 553
9. JH Lemmer Jr EW Dilling JR Morton JR Rich F Robicsek DL Bricker Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens Ann Thorac Surg 62 1996 1659 1668
10. JH Levy R Pifarré HV Schaff JC Horrow R Albus B Spiess A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting Circulation 92 1995 2236 2244
11. BP Bidstrup SR Underwood RN Sapsford E Streets Effects of aprotinin (Trasylol) on aorta-coronary bypass graft patency J Thorac Cardiovasc Surg 105 1993 147 153
12. RJ Prineas RS Crow H Blackburn The Minnesota Code manual of electrocardiographic findings: standards and procedures for measurement and classification 1982 John Wright PSG Littleton [MA] 1 229
13. PM Rautaharju HP Calhoun BR Chaitman Novacode serial ECG classification system for clinical trials in epidemiological studies J Electrocardiol 24 1992 179 187
14. BR Chaitman EL Alderman LT Sheffield T Tong L Fisher MB Mock Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery Circulation 67 1983 302 309
15. BR Chaitman SH Zhaou B Tamesis A Rosen AB Terry KM Zumbehl Methodology of serial ECG classification using an adaptation of the Novacode for Q wave myocardial infarction in the bypass angioplasty revascularization investigation (BARI) J Electrocardiol 29 1996 265 277
16. MA Paz J Lupon X Bosch JL Pomar G Sanz GESIC Study Group Predictors of early saphenous vein aortocoronary bypass graft occlusion Ann Thorac Surg 56 1993 1101 1106
17. JA Roth RA Cukingnan BG Brown E Gocka JS Carey Factors influencing patency of saphenous vein grafts Ann Thorac Surg 28 1979 176 183
18. VO Björk S Ekestrom A. Henze T Ivert C. Landou Early and late patency of aortocoronary vein grafts Scand J Thorac Cardiovasc Surg 15 1981 11 21
19. IK Crosby HA Wellons JG Taylor CJ Maffeo GA Beller WH Muller Critical analysis of the preoperative and operative predictors of aortocoronary bypass patency Ann Surg 193 1981 743 751
20. B Zingone A Salvi A Pappalardo A reappraisal of the factors affecting early patency of aortocoronary saphenous vein bypass grafts: current experience with extensive revascularization employing sequential grafting techniques G Ital Cardiol 15 1985 24 32
21. S Goldman J Copeland T Moritz W Henderson K Zadira T Ovitt Starting aspirin therapy after operation: effects on early graft patency Circulation 84 1991 520 526
22. FP Catinella JN Cunningham RK Srungaram FG Baumann IM Nathan EA Glassman The factors influencing early patency of coronary artery bypass vein grafts: correlation of angiographic and ultrastructural findings J Thorac Cardiovasc Surg 83 1982 686 700
23. OT Adcock Jr GL Adcock RE Wheeler RT Gregory SO Snyder Jr RG Gayle Optimal techniques for harvesting and preparation of reversed autogenous vein grafts for use as arterial substitutes: a review Surgery 96 1984 886 894
24. D Dries SF Mohammad SF Woodward RM Nelsen The influence of harvesting technique on endothelial preservation in saphenous veins J Surg Res 52 1992 219 225
25. GD Adcock OT Adcock Jr JR Wheeler Arterialization of reversed autogenous vein grafts: quantitative light and electron microscopy of canine jugular vein grafts harvested and implanted by standard or improved techniques J Vasc Surg 6 1987 283 295
26. HB Barner VW Fischer Endothelial preservation in human saphenous veins harvested for coronary grafting J Thorac Cardiovasc Surg 100 1990 148 149
27. EL Hoover M Ross K Fani Biochemical and histopathologic comparison between blood and saline storage of canine veins J Vasc Surg 7 1988 543 548
28. GM Lawrie DE Weilbacher PD Henry Endothelium-dependent relaxation in human saphenous vein grafts: effects of preparation and clinicopathologic correlations J Thorac Cardiovasc Surg 100 1990 612 620
29. HL Bush Jr JA Jakubowski GR Curl D Deykin DC Nabseth The natural history of endothelial structure and function in arterialized vein grafts J Vasc Surg 3 1986 204 215
30. JR Ramos K Berger PB Mansfield LR Sauvage Histologic fate and endothelial changes of distended and nondistended vein grafts Ann Surg 183 1976 205 228